Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE599.55-2.7 (-0.45 %)
PREV CLOSE ( ) 602.25
OPEN PRICE ( ) 610.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 433032
TODAY'S LOW / HIGH ( )590.85 617.00
52 WK LOW / HIGH ( )389.7 838
NSE599.75-2.1 (-0.35 %)
PREV CLOSE( ) 601.85
OPEN PRICE ( ) 612.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 599.75 (7329)
VOLUME 14551958
TODAY'S LOW / HIGH( ) 590.35 617.55
52 WK LOW / HIGH ( )389.35 838
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

19Feb Aurobindo Pharma receives EIR for Hyde
Aurobindo Pharma has received the Establishment Inspection Report (EIR)..
19Feb Aurobindo Pharma soars on receiving EI
Aurobindo Pharma is currently trading at Rs. 573.30, up by 73.10 points..
10Feb Aurobindo Pharma informs about loss of
Aurobindo Pharma has informed that the Company has received the letters..
01Feb SMS Pharma, BASF India and IndoStar Ca
SMS Pharmaceuticals has successful completed EDQM audit at Bachupally AP..
31Jan Aurobindo Pharma moves up on receiving
Aurobindo Pharma is currently trading at Rs. 482.35, up by 2.05 points o..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit4190.7000000000115297.3
Gross Profit 5493.00000000001 19646.2
Operating Profit 6891.6000000000125085.7
Net Sales 33456.7122578.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7322.90 (2.05%)
M.Cap ( in Cr)16865.09
Ajanta Pharma (BSE)
peergroup  1446.05 (10.03%)
M.Cap ( in Cr)12618.42
Ipca Laboratories (BSE)
peergroup  1456.15 (3.43%)
M.Cap ( in Cr)18398.76
Solara Active Pharma (BSE)
peergroup  680.25 (6.01%)
M.Cap ( in Cr)1772.41
Alkem Laboratories (BSE)
peergroup  2657.75 (1.39%)
M.Cap ( in Cr)31777.39

Shareholding Pattern

PROMOTERS 51.87%
NON-INSTITUTION 13.53%
MUTUAL FUNDS/UTI 12.78%
FI/BANKS/INSURANCE 0.4%
GOVERNMENT 0%
FII 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 599.55. Its current market capitalisation stands at Rs 35129.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Savita Mahajan, Avnit Bimal Singh, M Sitarama Murty, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, N Govindarajan, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are ACC Ltd. It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X